During the past decade, GU Research Network/Wichita Urology Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GU Research Network/Wichita Urology Group" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator and "Churchill Pharmaceutical LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "GU Research Network/Wichita Urology Group" are "Prostate Cancer" (3 trials), "Cancer of the Prostate" (2 trials), "Hormone Sensitive Prostate Cancer" (1 trials), "Nonmetastatic Castration-Resistant Prostate Cancer" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "GU Research Network/Wichita Urology Group" in a lesser frequency.

Most popular intervention types in "GU Research Network/Wichita Urology Group" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Enzalutamide" (2 trials), "Leuprolide" (1 trials), "Methylprednisolone" (1 trials) and "SoluMatrix™ Abiraterone Acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "GU Research Network/Wichita Urology Group" are 4 trials for "Male" genders.

Currently, there are NaN active trials in "GU Research Network/Wichita Urology Group". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in GU Research Network/Wichita Urology Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GU Research Network/Wichita Urology Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".